Previous close | 10.20 |
Open | 10.20 |
Bid | 9.80 |
Ask | 12.30 |
Strike | 240.00 |
Expiry date | 2024-12-20 |
Day's range | 10.20 - 10.20 |
Contract range | N/A |
Volume | |
Open interest | 2 |
Waters' (WAT) first-quarter 2024 results are likely to reflect strength in the large molecule and PFAS testing markets amid weakening demand in China.
Waters (WAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Waters Corporation (NYSE:WAT) today introduced new GTxResolve Premier Size Exclusion Chromatography (SEC) 1000Å 3-micron (3 µm) Columns. Waters has implemented a unique combination of novel packing materials and MaxPeak™ Premier High-Performance Surface (HPS) technology into the columns to help scientists accelerate the development of gene-based therapeutics, including cell & gene, mRNA and LNPs.